Literature DB >> 26223426

Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Alexandra Beilina1, Mark R Cookson2.   

Abstract

Substantial progress has been made in the genetic basis of Parkinson's disease (PD). In particular, by identifying genes that segregate with inherited PD or show robust association with sporadic disease, and by showing the same genes are found on both lists, we have generated an outline of the cause of this condition. Here, we will discuss what those genes tell us about the underlying biology of PD. We specifically discuss the relationships between protein products of PD genes and show that common links include regulation of the autophagy-lysosome system, an important way by which cells recycle proteins and organelles. We also discuss whether all PD genes should be considered to be in the same pathway and propose that in some cases the relationships are closer, whereas in other cases the interactions are more distant and might be considered separate. Beilina and Cookson review the links between genes for Parkinson's disease (red) and the autophagy-lysosomal system. They propose the hypothesis that many of the known PD genes can be assigned to pathways that affect (I) turnover of mitochondria via mitophagy (II) turnover of several vesicular structures via macroautophagy or chaperone-mediated autophagy or (III) general lysosome function. This article is part of a special issue on Parkinson disease. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Parkinson's disease; chaperone-mediated autophagy; genetics; lysosomes; mitophagy; protein complexes

Mesh:

Year:  2015        PMID: 26223426      PMCID: PMC5834228          DOI: 10.1111/jnc.13266

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  181 in total

1.  Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.

Authors:  Ana Maria Cuervo; Leonidas Stefanis; Ross Fredenburg; Peter T Lansbury; David Sulzer
Journal:  Science       Date:  2004-08-27       Impact factor: 47.728

2.  Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes.

Authors:  Andrew R J Young; Edmond Y W Chan; Xiao Wen Hu; Robert Köchl; Samuel G Crawshaw; Stephen High; Dale W Hailey; Jennifer Lippincott-Schwartz; Sharon A Tooze
Journal:  J Cell Sci       Date:  2006-08-29       Impact factor: 5.285

3.  The Arp2/3 activator WASH controls the fission of endosomes through a large multiprotein complex.

Authors:  Emmanuel Derivery; Carla Sousa; Jérémie J Gautier; Bérangère Lombard; Damarys Loew; Alexis Gautreau
Journal:  Dev Cell       Date:  2009-11       Impact factor: 12.270

4.  PINK1 and Parkin control localized translation of respiratory chain component mRNAs on mitochondria outer membrane.

Authors:  Stephan Gehrke; Zhihao Wu; Michael Klinkenberg; Yaping Sun; Georg Auburger; Su Guo; Bingwei Lu
Journal:  Cell Metab       Date:  2015-01-06       Impact factor: 27.287

5.  Selective escape of proteins from the mitochondria during mitophagy.

Authors:  Shotaro Saita; Michiko Shirane; Keiichi I Nakayama
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

7.  Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease.

Authors:  Shinji Higashi; Darren J Moore; Ryoko Yamamoto; Michiko Minegishi; Kiyoshi Sato; Takashi Togo; Omi Katsuse; Hirotake Uchikado; Yoshiko Furukawa; Hiroaki Hino; Kenji Kosaka; Piers C Emson; Keiji Wada; Valina L Dawson; Ted M Dawson; Heii Arai; Eizo Iseki
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

8.  VPS35 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Christian Wider; Owen A Ross; Justus C Dachsel; Jennifer M Kachergus; Sarah J Lincoln; Alexandra I Soto-Ortolaza; Stephanie A Cobb; Greggory J Wilhoite; Justin A Bacon; Bahareh Behrouz; Heather L Melrose; Emna Hentati; Andreas Puschmann; Daniel M Evans; Elizabeth Conibear; Wyeth W Wasserman; Jan O Aasly; Pierre R Burkhard; Ruth Djaldetti; Joseph Ghika; Faycal Hentati; Anna Krygowska-Wajs; Tim Lynch; Eldad Melamed; Alex Rajput; Ali H Rajput; Alessandra Solida; Ruey-Meei Wu; Ryan J Uitti; Zbigniew K Wszolek; François Vingerhoets; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

9.  Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2.

Authors:  David Ramonet; João Paulo L Daher; Brian M Lin; Klodjan Stafa; Jaekwang Kim; Rebecca Banerjee; Marie Westerlund; Olga Pletnikova; Liliane Glauser; Lichuan Yang; Ying Liu; Deborah A Swing; M Flint Beal; Juan C Troncoso; J Michael McCaffery; Nancy A Jenkins; Neal G Copeland; Dagmar Galter; Bobby Thomas; Michael K Lee; Ted M Dawson; Valina L Dawson; Darren J Moore
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

10.  PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.

Authors:  Lesley A Kane; Michael Lazarou; Adam I Fogel; Yan Li; Koji Yamano; Shireen A Sarraf; Soojay Banerjee; Richard J Youle
Journal:  J Cell Biol       Date:  2014-04-21       Impact factor: 10.539

View more
  24 in total

Review 1.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

2.  AAV-Mediated Expression of Dominant-Negative ULK1 Increases Neuronal Survival and Enhances Motor Performance in the MPTP Mouse Model of Parkinson's Disease.

Authors:  Dirk Balke; Lars Tatenhorst; Vivian Dambeck; Vinicius Toledo Ribas; Björn F Vahsen; Uwe Michel; Mathias Bähr; Paul Lingor
Journal:  Mol Neurobiol       Date:  2019-08-24       Impact factor: 5.590

Review 3.  Proteomics; applications in familial Parkinson's disease.

Authors:  Yan Li; Mark R Cookson
Journal:  J Neurochem       Date:  2019-07-09       Impact factor: 5.372

4.  Liver X Receptor Agonist GW3965 Regulates Synaptic Function upon Amyloid Beta Exposure in Hippocampal Neurons.

Authors:  C Báez-Becerra; F Filipello; A Sandoval-Hernández; H Arboleda; G Arboleda
Journal:  Neurotox Res       Date:  2018-01-03       Impact factor: 3.911

Review 5.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

Review 6.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

7.  The Parkinson's disease-linked protein TMEM230 is required for Rab8a-mediated secretory vesicle trafficking and retromer trafficking.

Authors:  Myung Jong Kim; Han-Xiang Deng; Yvette C Wong; Teepu Siddique; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2017-02-15       Impact factor: 6.150

Review 8.  The role of Rab GTPases in the pathobiology of Parkinson' disease.

Authors:  Luis Bonet-Ponce; Mark R Cookson
Journal:  Curr Opin Cell Biol       Date:  2019-05-01       Impact factor: 8.382

Review 9.  Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges.

Authors:  Lauren R Kett; William T Dauer
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

Review 10.  Parkinson's Disease Is Not Simply a Prion Disorder.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.